Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Illinois EC rule challenged

This article was originally published in The Tan Sheet

Executive Summary

A lawsuit challenging the Illinois regulation that requires all pharmacists to dispense emergency contraception was filed by the D.C.-based law group American Center for Law & Justice in Springfield, Ill. District Court Dec. 19. The suit represents five Walgreens pharmacists who were indefinitely suspended or fired for refusing to prescribe EC. The Illinois regulation was introduced as an "emergency rule" by Gov. Rod Blagojevich (D) in April and signed into law in August ("The Tan Sheet" June 20, 2005, p. 11). "This regulation targets religious views and practices in an unconstitutional manner," ACLJ Senior Counsel Francis Manion states in a same-day release...

You may also be interested in...



Plan B Illinois “Emergency Rule” Challenged In Pharmacist Suit

An Illinois "emergency rule" requiring pharmacists to dispense emergency contraceptive Plan B violates the state's Health Care Right of Conscience Act, according to a suit filed in Whiteside County, Ill. court June 8

Roche/Genentech Keeps Commitment To External Cancer Innovation

Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.

US FDA Eases Changes For Certain Sterile Injectable Container Closure Materials

To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.

Topics

UsernamePublicRestriction

Register

LL1135972

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel